Literature DB >> 8585885

Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.

G S Grubb1, D Moore, N G Anderson.   

Abstract

This report summarizes the data collected in pre-introductory Norplant implants clinical trials in 17 countries in Latin America, Asia and Africa that were coordinated by either the Population Council or Family Health International (FHI) between 1984 and 1991. A total of 16,282 women between the ages of 18 and 40 years participated in the studies with semi-annual or annual follow-up visits for up to 5 years. Gross cumulative pregnancy rates were < 0.6 per 100 women in the first year and < 1.5 in the second year in all countries. Significant differences in cumulative 5-year pregnancy rates were observed between weight groups 40-49 and 50-59 kg and between 50-59 and 60-69 kg body weight but not between 60-69 kg and those > or = 70 kg. Total cumulative discontinuation rates after five years of Norplant implants use ranged from 35.8 to 60.0 per 100 women. Younger age and low parity were associated with a higher discontinuation rate. Cumulative discontinuation rates for menstrual reasons more than doubled between the end of the first year and second year of use in 13 of 17 countries. This analysis and one previous review provide the only comparison of Norplant contraceptive system study results across a wide diversity of countries; thus allowing an appreciation of the range of clinical experience with Norplant implants and the regional differences in that experience.

Entities:  

Keywords:  Clinical Research; Clinical Trials; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Implants; Contraceptive Methods; Developing Countries; Diseases; Family Planning; Levonorgestrel; Menstruation Disorders; Research Methodology; Research Report

Mesh:

Substances:

Year:  1995        PMID: 8585885     DOI: 10.1016/0010-7824(00)10782-n

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

Review 1.  Levonorgestrel subdermal implants. Contraception on trial.

Authors:  M L Frank; C DiMaria
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

2.  Contraceptive use by obese women 1 year postpartum.

Authors:  Jeanette R Chin; Geeta K Swamy; Truls Østbye; Lori A Bastian
Journal:  Contraception       Date:  2009-05-09       Impact factor: 3.375

Review 3.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 4.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; Alissa Bernholc; Mario Chen; Thomas W Grey; Conrad Otterness; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.